Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0024 | 0.1234 | 0.5 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0024 | 0.1234 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.237 | 0.1295 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.237 | 0.1295 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0071 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.237 | 0.2136 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0024 | 0.1234 | 0.5 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0071 | 1 | 1 |
Treponema pallidum | NADH oxidase | 0.0024 | 0.1234 | 0.5 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0024 | 0.1234 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.237 | 0.1295 |
Brugia malayi | hypothetical protein | 0.002 | 0.0319 | 0.0319 |
Plasmodium vivax | glutathione reductase, putative | 0.0071 | 1 | 1 |
Leishmania major | trypanothione reductase | 0.0071 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0071 | 1 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0071 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.237 | 0.1295 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0024 | 0.1234 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.237 | 0.1295 |
Loa Loa (eye worm) | glutathione reductase | 0.0071 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0071 | 1 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0071 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0024 | 0.1234 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0071 | 1 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0071 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.003 | 0.237 | 0.237 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0071 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0024 | 0.1234 | 0.1234 |
Plasmodium falciparum | thioredoxin reductase | 0.0071 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0024 | 0.1234 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.237 | 0.1295 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0024 | 0.1234 | 0.5 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0024 | 0.1234 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.237 | 0.1295 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.237 | 0.1295 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0071 | 1 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0024 | 0.1234 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.